Oncology

David A. Boothman, Ph.D., Simmons Comprehensive Cancer Center


Friday, March 03, 2017 | 12 p.m. - 1 p.m. Add to Calendar

Leveraging NQO1 Bioactivatable Drugs or Tumor-Selective Use of PARP Inhibitors David A. Boothman, PhD Professor, Department of Pharmacology Associate Director for Translational Research Simmons Comprehensive Cancer Center For more information: events.houstonmethodist.org/David-A-Boothman


Location

Houston Methodist Research Institute

6670 Bertner Avenue

Contact

Houston Methodist Events

17133639049